NKGen Biotech to Present New Positive SNK01 Clinical Trial Biomarker Data at the 2024 Alzheimer's Association International Conference

More information about AAIC 2024 can be found at: https://aaic.alz.org/. A copy of the poster will be available on the Scientific Publications page of the Company's website at https://nkgenbiotech.com/ once the poster presentation has concluded. Previously disclosed Phase 1 data on the positive effects of SNK01 on amyloid, tau, and neuroinflammation biomarkers in Alzheimer's patients, which may not be included in this poster presentation, can also be found on the Scientific Publications webpage. About NKGen ...